knowledge -WSS

knowledge

author：fashion 2025-09-07 17:23:51 - browse：7426

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

WSS

Why patients can’t get everything they want on drug pricing

Dems pitch expanding Medicare power to negotiate drug prices

Will the FTC rein in IQVIA's health data empire?

Roche’s Alnylam deal shows drug firms interested in heart drugs

Congress might make insulin pumps more accessible to the blind

Resistance to opioid

focus

knowledge

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Congress might make insulin pumps more accessible to the blind

Supreme Court strikes down use of affirmative action

Readout Newsletter: Amylyx, Aurinia, and IQVIA

How one medical school became remarkably diverse

Democrats decry new health bill for going easy on private equity

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Here’s what’s in the FDA plan to include pregnant women in clinical trials

As demand for Covid shots wanes, Moderna seeks its next success

UHS says company favors patients whose insurance pays more

hotspot

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Abbott's new heart device gets FDA advisory panel nod

In the gardens at Boston Children's Hospital, families find sanctuary

STAT Report: Patient voices and perspectives

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

ACIP vaccine advisory panel sees its vacancies filled

focus

knowledge

leisure time

focus